Leap Therapeutics, Inc

(NASDAQ:LPTX)

Latest On Leap Therapeutics, Inc (LPTX):

Date/Time Type Description Signal Details
2023-05-15 12:07 ESTNewsLeap Therapeutics GAAP EPS of -$0.32 misses by $0.23N/A
2023-03-24 12:58 ESTNewsLeap Therapeutics GAAP EPS of -$0.11 in-lineN/A
2023-01-19 20:31 ESTNewsLeap rebounds as Astellas posts Phase 3 data for rival cancer candidateN/A
2023-01-17 09:37 ESTNewsLeap Therapeutics falls after all-stock deal to acquire Flame BiosciencesN/A
2022-11-16 14:24 ESTNewsLeap Therapeutics,(LPTX) Investor Presentation - SlideshowN/A
2022-11-14 11:22 ESTNewsLeap Therapeutics GAAP EPS of -$0.13 misses by $0.01N/A
2022-08-12 21:44 ESTNewsLeap Therapeutics GAAP EPS of -$0.15 misses by $0.05N/A
2022-07-12 11:37 ESTNewsLeap Therapeutics begins trials of DKN-01 in gastric/colorectal cancersN/A
2022-06-28 06:13 ESTNewsLeap Therapeutics: 2 Catalysts With Cancer Drug DKN-01 In The 2nd Half Of 2022N/A
2022-05-13 19:49 ESTNewsLeap Therapeutics GAAP EPS of -$0.09 beats by $0.01N/A
2022-03-11 14:12 ESTNewsLeap Therapeutics GAAP EPS of -$0.10 beats by $0.01, revenue of $0.38M beats by $0.08MN/A
2022-02-18 17:19 ESTNewsLeap Therapeutics: Waiting For One More LeapN/A
2022-01-31 19:28 ESTNewsLeap Therapeutics forms partnership to develop companion diagnostic for cancer patientsN/A
2022-01-29 02:59 ESTNewsLeap Therapeutics (LPTX) presents at 40th Annual JPMorgan Healthcare Conference (Slideshow)N/A
2022-01-29 02:59 ESTNewsLeap Therapeutics (LPTX) ASCO GI 2022 DisTinGuish Study Conference Call (Slideshow)N/A
2022-01-19 14:38 ESTNewsLeap Therapeutics updates Phase 2 data for DKN-01 combo in GIT cancerN/A
2021-11-30 07:24 ESTNewsLeap Therapeutics: What Prompted Prioritizing This Precision Oncology Company?N/A
2021-11-13 00:10 ESTNewsLeap Therapeutics EPS misses by $0.03, misses on revenueN/A
2021-10-15 17:04 ESTNewsLeap Therapeutics: Another Leap Coming UpN/A
2021-10-13 03:53 ESTNewsLeap Therapeutics: All On The LineN/A
2021-09-25 05:37 ESTNewsLeap Therapeutics (LPTX) ESMO 2021Virtual Congress Presentation - SlideshowN/A
2021-09-23 06:47 ESTNewsLeap Therapeutics plunges on stock and pre-funded warrants offeringN/A
2021-09-23 06:46 ESTNewsLeap Therapeutics slips on pricing equity offeringN/A
2021-09-21 23:43 ESTNewsLeap Therapeutics gains after announcing upcoming presentation for GIT cancer candidateN/A
2021-09-21 23:34 ESTNewsLAUR, LPTX, AERI and TWKS among after hours moversN/A
2021-09-21 23:34 ESTNewsLeap Therapeutics stock jumps 47% on positive DKN-01 + tislelizumab data in gastroesophageal cancerN/A
2021-09-21 23:22 ESTNewsMRIN, ALPN, SMMT and LPTX among after hours moversN/A
2021-08-13 16:33 ESTNewsLeap Therapeutics EPS in-line, beats on revenueN/A
2021-04-12 22:35 ESTNewsFlagship Biosciences and Leap Therapeutics ink RNAscope partnershipN/A
2021-03-22 09:24 ESTNewsLeap Therapeutics stock surges on positive mid-stage DKN-01 dataN/A
2021-03-16 21:19 ESTEarnings EstimateAn EPS average of -$0.57 is estimated for the 2022 year.Sell
2021-03-16 21:19 ESTEarnings EstimateAn EPS average of -$0.12 is estimated for the quarter ending on June 30, 2021.Sell
2021-03-14 00:10 ESTFinancialsCompany financials have been released.Neutral
2021-03-13 03:30 ESTNewsLeap Therapeutics EPS in-line, misses on revenueN/A
2021-03-03 00:24 ESTAnalyst RatingThe Analyst Target Price has increased from $5.1 to $5.3.Buy
2021-02-25 04:13 ESTAnalyst RatingThe Analyst Target Price has decreased from $5.4 to $5.1.Neutral
2021-02-24 11:55 ESTAnalyst RatingThe Analyst Target Price has increased from $5.1 to $5.4.Buy
2021-01-06 16:05 ESTFinancialsCompany financials have been released.Neutral
2020-11-26 20:43 ESTFinancialsCompany financials have been released.Neutral
2020-11-17 04:36 ESTFinancialsCompany financials have been released.Neutral
2020-11-14 04:35 ESTFinancialsCompany financials have been released.Neutral
2020-11-13 12:36 ESTEarnings EstimateAn EPS average of -$0.10 is estimated for the quarter ending on March 31, 2021.Sell
2020-11-13 03:25 ESTNewsLeap Therapeutics EPS beats by $0.04, beats on revenueN/A
2020-11-07 16:22 ESTFinancialsCompany financials have been released.Neutral
2020-09-26 13:18 ESTFinancialsCompany financials have been released.Neutral
2020-09-25 23:08 ESTNewsLeap Therapeutics Initiates Trial, And Other News: The Good, Bad And Ugly Of BiopharmaN/A
2020-09-24 18:13 ESTNewsLeap Therapeutics rallies on accelerated review status for lead drugN/A
2020-09-22 01:53 ESTNewsLeap Therapeutics/BeiGene initiates DKN-01+tislelizumab combination mid-stage study in gastric cancerN/A
2020-09-17 05:24 ESTFinancialsCompany financials have been released.Neutral
2020-09-15 19:25 ESTNewsLeap Therapeutics files for $150M mixed shelfN/A

About Leap Therapeutics, Inc (LPTX):

Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer. Its lead clinical stage programs include DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1 that is in multiple clinical trials for treating esophagogastric cancer, hepatobiliary cancer, gynecologic cancers, and prostate cancer. The company was formerly known as HealthCare Pharmaceuticals, Inc. and changed its name to Leap Therapeutics, Inc. in November 2015. Leap Therapeutics, Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

LPTX Quotes by TradingView

See Advanced Chart

General

  • Name Leap Therapeutics, Inc
  • Symbol LPTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 30
  • Fiscal Year EndDecember
  • IPO Date2017-01-25
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.leaptx.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 93.66
  • Price/Book (Most Recent Quarter) 2.56
  • Enterprise Value Revenue 69.95
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.46
  • Next Year EPS Estimate -$0.57
  • Next Quarter EPS Estimate -$0.10
  • Operating Margin -1887%
  • Return on Assets -57%
  • Return on Equity -123%
  • Revenue 1.5 million
  • Earnings Per Share -$1.66
  • Revenue Per Share $0.03
  • Gross Profit 1.5 million
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 148.55 million
  • EBITDA -34773000
  • PEG Ratio 0.75
  • Analyst Target Price $5.3
  • Book Value Per Share $0.78
View More

Share Statistics

  • Shares Outstanding 59.66 million
  • Shares Float 37.28 million
  • % Held by Insiders 1204%
  • % Held by Institutions 59.02%
  • Shares Short 1.22 million
  • Shares Short Prior Month 1.06 million
  • Short Ratio 1.24
  • Short % of Float 3%
  • Short % of Shares Outstanding 2%
View More

Technicals

  • Beta 1.34
  • 52 Week High $3.24
  • 52 Week Low $1.2
  • 50 Day Moving Average 2.48
  • 200 Day Moving Average 2.1
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Leap Therapeutics, Inc (LPTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Leap Therapeutics, Inc (LPTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-03-12$N/A-$0.09-$0.09-2.27%
2020-09-302020-11-12$375000-$0.09-$0.1329.69%
2020-06-302020-08-13$N/A-$0.12-$0.1833.33%
2020-03-312020-05-14$375000-$0.55-$0.25-124.49%
2019-12-312020-03-16$N/A-$0.32-$0.32-0.79%
2019-09-302019-11-14$N/A-$0.33-$0.330%
2019-06-302019-08-09$N/A-$0.37-$0.4312.94%
2019-03-312019-05-15$N/A-$0.47-$0.41-14.63%
2018-12-312018-12-31$N/A$0.12-$0.57121.05%
2018-09-302018-11-09$N/A-$0.45-$0.43-3.85%
2018-06-302018-08-08$N/A-$0.50-$0.49-2.04%
2018-03-312018-05-11$N/A-$0.85-$0.61-39.34%
2017-12-312018-02-23$N/A-$0.61-$0.8225.61%
2017-09-302017-11-13$N/A-$0.73-$0.62-18.7%
2017-06-302017-08-11$N/A-$0.74-$0.71-4.23%
2017-03-312017-05-12$N/A-$1.39-$0.87-60.69%
2016-12-312017-03-31$N/A-$0.60-$0.8025%

Leap Therapeutics, Inc (LPTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Leap Therapeutics, Inc (LPTX) Chart:

Leap Therapeutics, Inc (LPTX) News:

Below you will find a list of latest news for Leap Therapeutics, Inc (LPTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Leap Therapeutics, Inc (LPTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2024-05-1710CALL0 00TRUE00
2024-05-1720CALL0 095.85TRUE00
2024-05-1730.6CALL0 97150.45TRUE00
2024-05-1740.15CALL0 5105.82FALSE00
2024-05-1750.05CALL0 30FALSE00
2024-05-1760.25CALL0 240FALSE00
2024-05-1770CALL0 00FALSE00
2024-05-1710PUT0 00FALSE00
2024-05-1720.05PUT0 10FALSE00
2024-05-1730.2PUT4 38106.98FALSE0.20
2024-05-1740PUT0 0124.1TRUE00
2024-05-1750PUT0 0222.22TRUE00
2024-05-1760PUT0 0336.92TRUE00
2024-05-1770PUT0 0226.3TRUE00
2024-06-2112.43CALL0 30TRUE00
2024-06-2120.8CALL0 2122.66TRUE00
2024-06-2130.9CALL0 1150TRUE00
2024-06-2140.35CALL0 72135.93FALSE00
2024-06-2150.05CALL0 56131.02FALSE00
2024-06-2160.35CALL0 23146.81FALSE00
2024-06-2170.25CALL0 430FALSE00
2024-06-2180.13CALL0 100FALSE00
2024-06-2110PUT0 00FALSE00
2024-06-2120.2PUT0 11172.76FALSE00
2024-06-2130.5PUT0 54121.31FALSE00
2024-06-2140PUT0 0120.27TRUE00
2024-06-2150PUT0 0141.64TRUE00
2024-06-2160PUT0 0182.24TRUE00
2024-06-2170PUT0 0340.37TRUE00
2024-06-2180PUT0 0302.58TRUE00
2024-09-2010CALL0 0242.77TRUE00
2024-09-2021.4CALL0 50276.69TRUE00
2024-09-2031.5CALL0 3750TRUE00
2024-09-2040.77CALL0 70FALSE00
2024-09-2050.4CALL0 24162.98FALSE00
2024-09-2060.2CALL0 2133.61FALSE00
2024-09-2070.27CALL0 22138.58FALSE00
2024-09-2010PUT0 00FALSE00
2024-09-2020.35PUT0 5119.61FALSE00
2024-09-2030.77PUT0 71327.69FALSE00
2024-09-2041.35PUT0 1234.67TRUE00
2024-09-2050PUT0 0121.12TRUE00
2024-09-2060PUT0 0141.4TRUE00
2024-09-2070PUT0 0181.92TRUE00
2024-12-2010CALL0 00TRUE00
2024-12-2020CALL0 0267.92TRUE00
2024-12-2030CALL0 00TRUE00
2024-12-2040CALL0 00FALSE00
2024-12-2050CALL0 00FALSE00
2024-12-2060CALL0 0337.72FALSE00
2024-12-2010PUT0 00FALSE00
2024-12-2020PUT0 0111.88FALSE00
2024-12-2030PUT0 0145.98FALSE00
2024-12-2040PUT0 064.06TRUE00
2024-12-2050PUT0 0124.94TRUE00
2024-12-2060PUT0 0182.98TRUE00

Latest LPTX Trades:

Date Shares Price
Jun 13, 2022 7:59 PM EST100$1.01
Jun 13, 2022 7:59 PM EST40$1.015
Jun 13, 2022 7:59 PM EST100$1.02
Jun 13, 2022 7:59 PM EST5$1.01
Jun 13, 2022 7:59 PM EST195$1.01

Leap Therapeutics, Inc (LPTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920076856/0001104659-20-076856-index.htm
2018-07-26UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1509745/000000000018022988/0000000000-18-022988-index.htm
2018-08-10UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1509745/000000000018024784/0000000000-18-024784-index.htm
2019-08-06UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1509745/000000000019012107/0000000000-19-012107-index.htm
2018-08-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000005947818000198/0000059478-18-000198-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1509745/000005947819000077/0000059478-19-000077-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1509745/000031506619001161/0000315066-19-001161-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1509745/000031506620001085/0000315066-20-001085-index.htm
2020-04-203Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000089924320011022/0000899243-20-011022-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000089924320017581/0000899243-20-017581-index.htm
2018-09-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000104746918006052/0001047469-18-006052-index.htm
2019-01-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000104746919000318/0001047469-19-000318-index.htm
2019-02-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000104746919000333/0001047469-19-000333-index.htm
2019-04-0110-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1509745/000104746919001830/0001047469-19-001830-index.htm
2019-04-29DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1509745/000104746919002698/0001047469-19-002698-index.htm
2019-07-11424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000104746919004106/0001047469-19-004106-index.htm
2019-07-31S-1General form for registration of securities under the Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1509745/000104746919004464/0001047469-19-004464-index.htm
2019-08-13424B3Prospectus [Rule 424(b)(3)]https://www.sec.gov/Archives/edgar/data/1509745/000104746919004715/0001047469-19-004715-index.htm
2020-01-28PRE 14AOther preliminary proxy statementshttps://www.sec.gov/Archives/edgar/data/1509745/000104746920000550/0001047469-20-000550-index.htm
2020-02-10DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1509745/000104746920000772/0001047469-20-000772-index.htm
2020-03-1610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1509745/000104746920001500/0001047469-20-001500-index.htm
2020-04-28DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1509745/000104746920002655/0001047469-20-002655-index.htm
2020-06-17424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000104746920003667/0001047469-20-003667-index.htm
2020-06-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000104746920003711/0001047469-20-003711-index.htm
2018-05-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918032365/0001104659-18-032365-index.htm
2018-07-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918046384/0001104659-18-046384-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048857/0001104659-18-048857-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048858/0001104659-18-048858-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048859/0001104659-18-048859-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048861/0001104659-18-048861-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048862/0001104659-18-048862-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048863/0001104659-18-048863-index.htm
2018-08-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918048864/0001104659-18-048864-index.htm
2018-08-0810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465918050309/0001104659-18-050309-index.htm
2018-08-0810-Q/AQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465918050310/0001104659-18-050310-index.htm
2018-08-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918050319/0001104659-18-050319-index.htm
2018-08-08CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1509745/000110465918050321/0001104659-18-050321-index.htm
2018-09-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918055815/0001104659-18-055815-index.htm
2018-09-10SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1509745/000110465918056029/0001104659-18-056029-index.htm
2018-10-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918063175/0001104659-18-063175-index.htm
2018-11-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465918067133/0001104659-18-067133-index.htm
2018-11-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918067138/0001104659-18-067138-index.htm
2018-11-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918069217/0001104659-18-069217-index.htm
2018-12-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465918072952/0001104659-18-072952-index.htm
2018-12-143Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465918073109/0001104659-18-073109-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000504/0001104659-19-000504-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000506/0001104659-19-000506-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000507/0001104659-19-000507-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000508/0001104659-19-000508-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000509/0001104659-19-000509-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000511/0001104659-19-000511-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000512/0001104659-19-000512-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000513/0001104659-19-000513-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919000514/0001104659-19-000514-index.htm
2019-01-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919001677/0001104659-19-001677-index.htm
2019-01-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919004285/0001104659-19-004285-index.htm
2019-01-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919004796/0001104659-19-004796-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919004959/0001104659-19-004959-index.htm
2019-02-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919005171/0001104659-19-005171-index.htm
2019-02-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919005834/0001104659-19-005834-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919005835/0001104659-19-005835-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919005836/0001104659-19-005836-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919005837/0001104659-19-005837-index.htm
2019-02-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919005838/0001104659-19-005838-index.htm
2019-02-08SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1509745/000110465919006865/0001104659-19-006865-index.htm
2019-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919015410/0001104659-19-015410-index.htm
2019-04-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919018969/0001104659-19-018969-index.htm
2019-04-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1509745/000110465919018973/0001104659-19-018973-index.htm
2019-05-1510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465919029515/0001104659-19-029515-index.htm
2019-05-158-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919029518/0001104659-19-029518-index.htm
2019-05-208-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919030392/0001104659-19-030392-index.htm
2019-06-11S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919034806/0001104659-19-034806-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035072/0001104659-19-035072-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035073/0001104659-19-035073-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035074/0001104659-19-035074-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035075/0001104659-19-035075-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035076/0001104659-19-035076-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035077/0001104659-19-035077-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035078/0001104659-19-035078-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035079/0001104659-19-035079-index.htm
2019-06-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035081/0001104659-19-035081-index.htm
2019-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919035828/0001104659-19-035828-index.htm
2019-07-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919039889/0001104659-19-039889-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919044131/0001104659-19-044131-index.htm
2019-08-06CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1509745/000110465919044336/0001104659-19-044336-index.htm
2019-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465919045018/0001104659-19-045018-index.htm
2019-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919045024/0001104659-19-045024-index.htm
2019-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919050329/0001104659-19-050329-index.htm
2019-11-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465919063689/0001104659-19-063689-index.htm
2019-11-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919063698/0001104659-19-063698-index.htm
2019-11-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465919066665/0001104659-19-066665-index.htm
2020-01-038-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920000583/0001104659-20-000583-index.htm
2020-01-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920002039/0001104659-20-002039-index.htm
2020-02-13DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1509745/000110465920020256/0001104659-20-020256-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920029235/0001104659-20-029235-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920029236/0001104659-20-029236-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920029237/0001104659-20-029237-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920029239/0001104659-20-029239-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920029241/0001104659-20-029241-index.htm
2020-03-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920029242/0001104659-20-029242-index.htm
2020-03-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920030492/0001104659-20-030492-index.htm
2020-03-168-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920033628/0001104659-20-033628-index.htm
2020-03-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920035463/0001104659-20-035463-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920035911/0001104659-20-035911-index.htm
2020-03-20S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920036435/0001104659-20-036435-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920043887/0001104659-20-043887-index.htm
2020-04-063Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920043888/0001104659-20-043888-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046072/0001104659-20-046072-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046073/0001104659-20-046073-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046074/0001104659-20-046074-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046075/0001104659-20-046075-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046076/0001104659-20-046076-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046077/0001104659-20-046077-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046078/0001104659-20-046078-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046079/0001104659-20-046079-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046080/0001104659-20-046080-index.htm
2020-04-158-K/ACurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920046854/0001104659-20-046854-index.htm
2020-04-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920050023/0001104659-20-050023-index.htm
2020-05-1410-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465920061137/0001104659-20-061137-index.htm
2020-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920061150/0001104659-20-061150-index.htm
2020-06-11DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1509745/000110465920072491/0001104659-20-072491-index.htm
2020-06-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920072493/0001104659-20-072493-index.htm
2020-06-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920074164/0001104659-20-074164-index.htm
2020-06-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920074453/0001104659-20-074453-index.htm
2020-06-198-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920075290/0001104659-20-075290-index.htm
2020-06-228-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920075628/0001104659-20-075628-index.htm
2020-06-258-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920076856/0001104659-20-076856-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094191/0001104659-20-094191-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094192/0001104659-20-094192-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094193/0001104659-20-094193-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094194/0001104659-20-094194-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094195/0001104659-20-094195-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094197/0001104659-20-094197-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094199/0001104659-20-094199-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094201/0001104659-20-094201-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094203/0001104659-20-094203-index.htm
2020-08-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094204/0001104659-20-094204-index.htm
2020-08-1310-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1509745/000110465920094304/0001104659-20-094304-index.htm
2020-08-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920094315/0001104659-20-094315-index.htm
2020-09-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920104009/0001104659-20-104009-index.htm
2020-09-14S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1509745/000110465920104928/0001104659-20-104928-index.htm
2020-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920106756/0001104659-20-106756-index.htm
2020-09-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1509745/000110465920108142/0001104659-20-108142-index.htm
2020-10-14S-3/ARegistration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1509745/000110465920114977/0001104659-20-114977-index.htm
2019-02-15SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1509745/000119312519042513/0001193125-19-042513-index.htm
2020-01-21SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1509745/000119312520011112/0001193125-20-011112-index.htm
2020-04-20SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1509745/000119312520112313/0001193125-20-112313-index.htm
2020-08-213Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000156761920015870/0001567619-20-015870-index.htm
2020-03-233Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1509745/000165130820000029/0001651308-20-000029-index.htm
2020-03-23SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1509745/000165130820000030/0001651308-20-000030-index.htm
2019-08-08EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1509745/999999999519001841/9999999995-19-001841-index.htm
2020-10-16EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1509745/999999999520002888/9999999995-20-002888-index.htm

Leap Therapeutics, Inc (LPTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Leap Therapeutics, Inc (LPTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1204%
Institutional Ownership: 5902%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-02-05AUGUSTINE LAWLORChief Operating OfficerBuy571,428.001.75999,999.004,114,804.00https://www.sec.gov/Archives/edgar/data/1509745/000110465919005837/0001104659-19-005837-index.htm
2019-02-05Christopher MirabelliCEO, President, ChairmanBuy571,428.001.75999,999.004,114,804.00https://www.sec.gov/Archives/edgar/data/1509745/000110465919005836/0001104659-19-005836-index.htm
2019-02-05DOUGLAS E ONSICFO, GC, Treasurer & SecretaryBuy571,428.001.75999,999.004,114,804.00https://www.sec.gov/Archives/edgar/data/1509745/000110465919005838/0001104659-19-005838-index.htm
2019-02-05HealthCare Ventures IX, L.P.10% Share HolderBuy571,428.001.75999,999.004,144,804.00https://www.sec.gov/Archives/edgar/data/1509745/000110465919005835/0001104659-19-005835-index.htm
2020-06-22PERCEPTIVE ADVISORS LLC10% Share HolderBuy1,750,000.002.003,500,000.008,476,496.00https://www.sec.gov/Archives/edgar/data/1509745/000089924320017581/0000899243-20-017581-index.htm